Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
ABT
VRTX
Add up to 3 more stocks
ABT
Abbott Laboratories
+1.58%
$114.46+1.78Delayed quote: Aug 19, 2026, 3:59 PM EDT
Market Cap
$198.06B
52W Range
$81.97 - $137.49
VRTX
Vertex Pharmaceuticals Incorporated
+4.52%
$552.06+23.87At close: Aug 19, 2026, 4:00 PM ET
Market Cap
$140.12B
52W Range
$374.17 - $553.69
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | 36.79 | 32.13 |
| Forward P/E | 20.75 | 29.41 |
| P/B Ratio | 3.90 | 6.97 |
| P/S Ratio | 4.28 | 11.18 |
| P/FCF Ratio | 22.87 | 37.19 |
| EV/EBITDA | 20.84 | 26.91 |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 56.8% | 86.0% |
| Operating Margin | 17.0% | 38.6% |
| Net Margin | 11.7% | 34.9% |
| ROE | 10.6% | 21.8% |
| ROA | 5.0% | 16.1% |
| ROIC | 6.1% | 17.3% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 1.38 | 3.19 |
| Quick Ratio | 0.97 | 2.74 |
| Debt/Equity | 0.64 | 0.10 |
| Interest Coverage | 23.60 | 357.95 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | 2.2% | N/A |
| Payout Ratio | 66.3% | N/A |
| Yrs of Dividend Growth | 52 | 0 |
N/A includes metrics that are structurally not meaningful for a company's sector (e.g. EV multiples, free-cash-flow ratios, and working-capital ratios for banks and insurers). Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.